The first and only ready-to-use presentation of fosaprepitant — without the need for dilution or reconstitution 1,2
FOCINVEZ™ is supplied in the dose strength of 150 mg/50 mL (3 mg/mL). 1 Please see Full Prescribing Information for a complete list of indications and dosing schedule.
References: 1. Focinvez. Prescribing information. Amneal Pharmaceuticals LLC; 2023. 2. US Food and Drug Administration. Orange book: Approved drug products with therapeutic equivalence evaluations. Accessed May 13, 2024. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm